REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/27/2026
Back to search
Official data from USPTO
POLYPEPTIDE GROUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
04/28/2026
Trademark type
Combined
Nice classes
1, 5, 40, 42
Filing date
08/21/2019
Registration date
04/27/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/27/2021
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
SE
Examiner
MICKLEBURGH, LINDA BOHANNON
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an atomic model overlaying a graph point to the left of the words "POLYPEPTIDE GROUP".
Holders and representatives
Holders
Polypeptide Laboratories Holding (PPL) AB
Polypeptide Laboratories Holding B.V.
Representatives
Michelle Hon Donovan Duane Morris LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations comprised in significant part of peptides for use in industry and science
Class 5
Pharmaceutical and veterinary preparations comprised in significant part of peptides for the treatment of various medical conditionsnamely viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disordershematologicalneurodegenerative and nephrological diseasesreproductive health and complement system related diseases and cancer; biological preparations comprised in significant part of polypeptides for medical and veterinary purposes for the treatment of various medical conditionsnamely viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disordershematologicalneurodegenerative and nephrological diseasesreproductive health and complement system related diseases and cancer; medicated shampoosmedicated hair lotionsmedicated soapsmedicated cosmetics
Class 40
Custom manufacturing services for others in the field of peptide manufacturing
Class 42
Research and development services in the field of peptide manufacturing
Publications
History of USPTO decisions and trademark events.
41 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/18/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/11/2021
FIMP
FINAL DISPOSITION PROCESSED
08/11/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/27/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/27/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/09/2021
PUBO
PUBLISHED FOR OPPOSITION
02/09/2021
GPNX
NOTIFICATION PROCESSED BY IB
02/06/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/20/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
01/06/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/06/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
01/06/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/06/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/06/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/18/2020
GNRT
NON-FINAL ACTION E-MAILED
06/18/2020
CNRT
NON-FINAL ACTION WRITTEN
06/18/2020
DOCK
ASSIGNED TO EXAMINER
06/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2020
RFNT
REFUSAL PROCESSED BY IB
03/27/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/20/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/02/2020
RFRR
REFUSAL PROCESSED BY MPU
03/02/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/07/2020
CNRT
NON-FINAL ACTION WRITTEN
02/06/2020
MAFR
APPLICATION FILING RECEIPT MAILED
02/04/2020
DOCK
ASSIGNED TO EXAMINER
01/31/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/31/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/30/2020
Continuous trademark protection
Get notified about every new filing that threatens POLYPEPTIDE GROUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.